Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

The First Registry: Follow-up in Rivaroxaban Patients in the Setting of Venous Thromboembolism

Kathryn Jane Lang, MRCP, MBBS, Vicente Solis, Jignesh Patel, PhD, Julia Czuprynska, MBBS, Lara N Roberts, MD, Raj Patel, Roopen Arya

Blood (2015) 126 (23): 4737.

https://doi.org/10.1182/blood.V126.23.4737.4737

Published: 2015

Journal Articles

Screening for Occult Malignancy Following First Unprovoked VTE: A Single Centre Experience

Ruochen Li, BA (Hons), MB BChir, Cara Doyle, BN (Hons) RGN, Lara N Roberts, MD, Kathryn Jane Lang, MRCP, MBBS, Emma Gee, Julia Czuprynska, MBBS, Raj K Patel, MD, Roopen Arya, PhD

Blood (2015) 126 (23): 3550.

https://doi.org/10.1182/blood.V126.23.3550.3550

Published: 2015

Journal Articles

The Impact of Implementation of a Comprehensive Venous Thromboembolism Prevention Programme on the Incidence and Characteristics of Hospital-Associated Thrombosis: A Single Centre Experience

Victoria van Hamel Parsons, BMBCh, BA, Lara N Roberts, MD, Cara Doyle, BN (Hons) RGN, Gayle Mulla, MSc Adult Nursing, Adam Pennycuick, MBBS, MPhys, Roopen Arya, PhD

Blood (2015) 126 (23): 4442.

https://doi.org/10.1182/blood.V126.23.4442.4442

Published: 2015

Journal Articles

Patients Prescribed Warfarin with Poor Time in Therapeutic Range (TTR) Have Different Beliefs about Their Illness and Anticoagulation Therapy Compared to Those with a Good TTR - Early Results from the Switching Study

John K Abdou, MPharm, Jignesh P Patel, PhD, Bipin Vadher, MD, Alison Brown, BPharm, Lara N Roberts, MD, Raj K Patel, MD, Roopen Arya, PhD, Vivian Auyeung, PhD

Blood (2015) 126 (23): 2331.

https://doi.org/10.1182/blood.V126.23.2331.2331

Published: 2015

Journal Articles

Do the Safety and Efficacy Outcomes Reported in the Clinical Trials of Direct Oral Anticoagulants (DOAC) Translate to the Real-World?

Shammim Haji, MPharm, Jignesh P Patel, PhD, Vivian Auyeung, PhD, Lara N Roberts, MD, Julia Czuprynska, MBBS, Raj K Patel, MD, Roopen Arya, PhD

Blood (2015) 126 (23): 2335.

https://doi.org/10.1182/blood.V126.23.2335.2335

Published: 2015

NARROW

The First Registry: Follow-up in Rivaroxaban Patients in the Setting of Venous Thromboembolism

Screening for Occult Malignancy Following First Unprovoked VTE: A Single Centre Experience

The Impact of Implementation of a Comprehensive Venous Thromboembolism Prevention Programme on the Incidence and Characteristics of Hospital-Associated Thrombosis: A Single Centre Experience

Patients Prescribed Warfarin with Poor Time in Therapeutic Range (TTR) Have Different Beliefs about Their Illness and Anticoagulation Therapy Compared to Those with a Good TTR - Early Results from the Switching Study

Do the Safety and Efficacy Outcomes Reported in the Clinical Trials of Direct Oral Anticoagulants (DOAC) Translate to the Real-World?

Email alerts

ASH Publications

American Society of Hematology

The First Registry: Follow-up in Rivaroxaban Patients in the Setting of Venous Thromboembolism

Screening for Occult Malignancy Following First Unprovoked VTE: A Single Centre Experience

The Impact of Implementation of a Comprehensive Venous Thromboembolism Prevention Programme on the Incidence and Characteristics of Hospital-Associated Thrombosis: A Single Centre Experience

Patients Prescribed Warfarin with Poor Time in Therapeutic Range (TTR) Have Different Beliefs about Their Illness and Anticoagulation Therapy Compared to Those with a Good TTR - Early Results from the Switching Study

Do the Safety and Efficacy Outcomes Reported in the Clinical Trials of Direct Oral Anticoagulants (DOAC) Translate to the Real-World?

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only